Even before a tumor in the pancreas becomes discernible, an activated cancer gene actively remodels its future environment and creates an inflammatory and immune-defensive microenvironment in which ...

Researchers identified blood-based biomarkers that predict which glioblastoma patients respond best to the oncolytic virus ...

Investigators reviewed medical literature to determine the prevalence of breast cancer screening among female survivors of a prior cancer other than breast cancer and to compare the likelihood of ...

Cancer cannot be explained by mutations alone. Today, cancer is understood as a multifactorial disease, shaped by genetics, ...

Hyderabad are advancing cancer research by integrating genomics, epigenetics, gene regulation and artificial intelligence to identify tumour-driving mutations, cancer subtypes and early diagnostic ...

A recent study shows that people with the highest intake of ultraprocessed foods had a 48% higher rate of death from any ...

Cancer is no longer seen as a single genetic error but as a complex, multi-layered disease shaped by DNA mutations, epigenetic changes and even patterns in medical images. New research at ...

In a conversation with Pharmaceutical Executive, Phesi founder and CEO Gen Li discusses his company’s recent global analysis of clinical trials. While the report once again showed that breast cancer ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

Regenerative Medicine Advanced Therapy (RMAT) designation requests update submitted to FDA with recent biomarker data ...

Feb 13 (Reuters) - Patients with one of the deadliest gynecological cancers had dramatically improved survival when an experimental drug was added to treatment with a standard chemotherapy medication ...